Last Updated on November 9, 2024 by The Health Master
Drug alert
Drug alert: Download the list of NSQ samples for September 2024, the link is given below: 67 drug samples declared as not of standard quality (NSQ), nationwide.
NSQ Lists are given below the article
Out of these 67 samples, 49 were declared NSQ by CDSCO and 18 were declared NSQ by various STATES across India.
Details of the NSQ samples declared by STATES is as under:
| Sr. | Name of STATES | Number of NSQ samples declared |
| 1 | Kerala | 15 |
| 2 | J&K | 3 |
| Total | 18 |
NOTE:
- NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Karnataka (PDF format), Thiruvanthapuram (Excel format), and Jammu Kashmir (Excel Format) for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
- State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Goa, Gujarat, Haryana, Himachal Pradesh, Manipur, Rajasthan, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry, Telangana, Delhi, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
Drug alert: Previous months
August 2024: 59 drug samples declared as NSQ, out of these 59 samples, 48 were declared NSQ by CDSCO and 11 were declared NSQ by various STATES across India.
July 2024: 70 drug samples declared as NSQ, out of these 70 samples, 57 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
June 2024: 61 drug samples declared as NSQ, out of these 61 samples, 31 were declared NSQ by CDSCO and 30 were declared NSQ by various STATES across India.
May 2024: 52 drug samples declared as NSQ, out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
April 2024: 50 drug samples declared as NSQ, out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.
During the month of March 2024, the authorities tested 931 samples, out of which 864 were of standard quality. The number of samples declared as not of standard quality was 66, with one being misbranded and none being spurious.
During the month of February 2024, the authorities tested 1167 samples, out of which 1018 were of standard quality. The number of samples declared as not of standard quality was 58, with none being misbranded and two being spurious.
During the month of January 2024, the authorities tested 932 samples, out of which 886 were of standard quality. The number of samples declared as not of standard quality was 46, with none being misbranded and none being spurious.
During the month of December 2023, the authorities tested 1008 samples, out of which 930 were of standard quality. The number of samples declared as not of standard quality was 78, with none being misbranded and none being spurious.
During the month of November 2023, the authorities tested 1197 samples, out of which 1133 were of standard quality. The number of samples declared as not of standard quality was 62, with one being misbranded and one being spurious.
During the month of October 2023, the authorities tested 1105 samples, out of which 1044 were of standard quality. The number of samples declared as not of standard quality was 61, with none being misbranded and none being spurious.
During the month of September 2023, the authorities tested 1188 samples, out of which 1126 were of standard quality. The number of samples declared as not of standard quality was 62, with none being misbranded and none being spurious.
During the month of August 2023, the authorities tested 1166 samples, out of which 1118 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and none being spurious.
The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, and Guwahati.
Drug alert: 59 drug samples declared as NSQ in August 2024
Drug alert: 70 drug samples declared as NSQ in July 2024
Drug alert: 61 drug samples declared as NSQ in June 2024
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Commercial Testing Laboratories
Latest Notifications: Testing Laboratories
Commercial Testing Laboratories
Commercial Testing Laboratories: Procedure
Updated list of Medical Device Testing Laboratories (MDTLs)
List of Laboratory Instruments for Pharma & Cosmetics Industry
Calibration of Laboratory Instruments
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
Laboratory Waste Management, Types and Its Disposal
NABL certification procedure for Laboratories
Quality Assurance Vs Quality Control in the Pharma Industry
NABL certification for Laboratories: Let’s understand
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
Licensing procedure for manufacturing of Drugs
Procedure to obtain license for manufacturing of Cosmetics
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Procedure to obtain license for manufacturing of Medical Devices
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Blood Centre (Blood Bank)
Procedure to obtain license for Commercial Testing Laboratories
Govt rejects review applications from 5 Pharma Companies on pricing of Metoprolol
USFDA declines to approve this Hormone Disorder Drug
DTAB recommends Stricter Qualifications for Wholesale Drug Licenses
Price fixation of Wysolone DT Tablets: Review application rejected
Two new Drug Testing Laboratories open: Gujarat FDCA
Streamlining Pharma Exports: DGFT Introduces Electronic Submission system
DTAB agrees with proposal to amend New Drugs and Clinical Trials Rules
Drug recall: Gilead recalled this drug after failed trial
List of Drugs declared as NSQ by CDSCO for the Month of September– 2024.
As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.
| A. CDSCO/Central Laboratories | |||||||
| S.No | Product/Drug Name | Batch No. | Manufacturin g Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
| 1. | Metronidazole Tablets I.P. 400 mg | HMAA04 | 07/2023 | 06/2025 | M/s. Hindustan Antibiotics Ltd., At: 11 W.E.A. Faridabad – 121001 (Haryana) R.O. Pimpri, Pune – 411 018, India | Dissolution | CDL, Kolkata |
| 2. | Domperidon Suspension (Vomitel) | U587F2401 | 06/2024 | 05/2026 | M/s. Rainbow Life Sciences Pvt. Ltd., C/o. Unijules Life Sciences Ltd., B-35, 36, MIDC Kalmeshwar, Nagpur 441 501. | Assay | CDL, Kolkata |
| 3. | Oxytocin Injection I.P. 5 IU/1 ml | OTC-382A | 04/2023 | 03/2025 | M/s. Pushkar Pharma, Kheri, Kala Amb – 173030 (H.P.). | Description, Particulate matter & Assay of Oxytocin | CDL, Kolkata |
| 4. | Metformin Hydrochloride 500 mg SR & Glimepiride 2 mg Tablets IP (SPAMET GM 2 Tablets) | TF147A | 02/2024 | 01/2026 | M/s. Swiss Biotech Parenterals , Kewat No. 1138, VPO – Kachhwa, Karnal- 132001, Haryana | Dissolution of Glimepiride | CDL, Kolkata |
| 5. | Diclofenac Sodium Tablets IP 50 mg | HDFA02 | 11/2023 | 10/2025 | M/s. Hindustan Antibiotics Ltd., At: 11 W.E.A. Faridabad – 121001 (Haryana) R.O. Pimpri, Pune – 411 018, India | Dissolution | CDL, Kolkata |
| 6. | Calcium Gluconate Injection I.P. 10 ml | MA24E55 | 05/2024 | 04/2026 | M/s. Martin & Brown Biosciences Pvt. Ltd., K. No. 918/419, Malkumajra, Nalagarth Road, Baddi, Dist. Solan (H.P.) 173205 | Description & Particulate matter | CDL, Kolkata |
| 7. | Oxytocin Injection I.P. 1 ml | 22X23002 | 07/2023 | 06/2027 | M/s. Radiant Parenterals Ltd., 242/4, 5 & 6, G.I.D.C. Estate at & Post Waghodia, Dist. Vadodara, Gujarat 391 760. | Assay | CDL, Kolkata |
| 8. | Ceftriiaxone Injection I.P. 1g | 324476 | 04/2024 | 03/2026 | M/s. Zee Laboratories Ltd., Behind 47, Industrial Area, Paonta Sahib-173025 | Particulate Matter & Clarity of Solution | CDL, Kolkata |
| 9. | Gentamycin Sulphate Injection I.P. 40 mg/ml | 324-564 | 05/2024 | 04/2026 | M/s. Zee Laboratories Ltd., Behind 47, Industrial Area, Paonta Sahib-173025 | Description & Particulate matter | CDL, Kolkata |
| 10. | Glycopyrrolate 0.5 mg / 5ml + Neostigmine methysulfate Injection 2.5 mg / 5ml) (Stimin) | GNI2406AC | 07/2024 | 06/2026 | M/s. Celon Laboratories Pvt. Ltd., Plot No. 2, ALEAP Industrial Estate, Gajularamaram, Medchal District – 500 090, Telangana State, India. | Description & Clarity of Solution | CDL, Kolkata |
| 11. | Ketoconazole Cream BP (Nozal Cream) | 4129 | 01/07/2024 | 30/06/20 26 | M/s. Olcare Laboratories 505/A, GIDC Estate, Wadhwan City – 363035, Dist. Surendranagar, Gujarat | Assay | CDL, Kolkata |
| 12. | Heparin Sodium Injection IP 5000 IU / 5ml (Hepathin 5000 Injection 5 ml / vial) | L1192317G | 08/2023 | 07/2025 | M/s. Protech Telelinks, Mauza Ogli, Suketi Road, Kala Amb, Dist- Sirmour (H.P.) 173030 | Description & Particulate matter | CDL, Kolkata |
| 13. | Heparin Sodium Injection IP 5000 IU / 5ml (Hepathin 5000 Injection 5 ml / vial) | L1192317C | 08/2023 | 07/2025 | M/s. Protech Telelinks, Mauza Ogli, Suketi Road, Kala Amb, Dist- Sirmour (H.P.) 173030 | Description, Particulate matter and Assay of Heparin (Anti- factor IIa activity) | CDL, Kolkata |
| 14. | Gentamicin Injection I.P. (Gentagain ) | IGMJ330 | 10/2023 | 09/2025 | M/s. Regain Laboratories 134/5, HTM Road, Raipur Lane, Hisar-125001 | Description & Particulate matter | CDL, Kolkata |
| 15. | Glipizide Tablets I.P. 5 mg | Z24-187 | 02/2024 | 01/2026 | M/s. Zee Laboratories Ltd., Behind 47, Industrial Area, Paonta Sahib-173205 | Dissolution | CDL, Kolkata |
| 16. | Omeprazole & Domperidone Capsules IP (Omerin-D Capsules) | RC-331223 | 12/2023 | 11/2025 | M/s. Renowed Life Sciences, Plot No-12, Sector-6B, SIDCUL,, Haridwar, Uttarakhand (India) 249403 | Dissolution of Omeprazole | CDL, Kolkata |
| 17. | Dried Aluminium Hydroxide, Magnesium Hydroxide & Activated Dimethicone Suspension (Chill Acid MPS) | DNS- 2210001 | 10/2022 | 09/2024 | M/s. Devout Nord (I) Ltd., Plot No. 28B, Sector-8B, IIE, Sidcul, Haridwar-249 403 (U.K). | Description, Microbial Limit Test, Identification and Assay of Activated Dimethicone | CDL, Kolkata |
| 18. | Nimesulide & Paracetamol Tablets (Nimuvent-P Tablets) | GD332005 | 04/2022 | 03/2025 | M/s. Innova Captab Limited, 1281/1, Hilltop Industrial Estate, Near EPIP, Phase-I, Jharmajri, Baddi, Dist. Solan (H.P.) | Description | CDL, Kolkata |
| 19. | Cipronir 500 (Ciprofloxacin Tablets IP 500 mg) | CCF212003 | 12/2022 | 11/2025 | M/s. Celebrity Biopharma Ltd., Vill. Panga, Via – Jharmajri, Hill Top Estate, Barotiwala, Distt. Solan, H.P. 174103 | Dissolution | CDL, Kolkata |
| 20. | Ofloxacin & Ornidazole Tablets I.P. (SMB OZ TABLETS) | B22-114 | 08/2022 | 07/2025 | M/s. Saint Michael Biotech, No. 130, Village Kurdi, Manglore, Jharbrera Road, Roorkee- 247656 (Haridwar) (U.K.) | Dissolution of Ofloxacin & Ornidazole | RDTL, Guwahati |
| 21. | Calcium 500 mg and Vitamin D3 250 IU Tablets IP | LMT240025 | 01/2024 | 12/2025 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector 6A, IIE, SIDCUL, Haridwar249403 (U.K) | Assay of Calcium and Vitamin D3 and Dissolution of Calcium | RDTL, Guwahati |
| 22. | Loperamide Hydrochloride Tablets I.P. 2 mg (LOMJAN) | L-2401 | 01/2024 | 12/2025 | M/s.Arya Pharmaceuticals, 111- c, Industrial Estate, Indore-15. | Dissolution and Assay/ Content of Loperamide Hydrochloride and Description | RDTL, Guwahati |
| 23. | Glimepiride Tablets IP 1 mg | LMT240339 | 03/2024 | 02/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector6A, IIE, SIDCUL, Haridwar249403 (U.K) | Dissolution | RDTL, Guwahati |
| 24. | Fexofenadine Hydrochloride Tablets I.P. | 658-021 | 11/2023 | 10/2025 | M/s. Signature Phytochemical Industries, 122, MI, Selaqui Industrial Area, Dehradun – 248 011. | Dissolution | RDTL, Guwahati |
| 25. | Glimepiride Tablets I.P. 2 mg | LMT240157 | 02/2024 | 01/2026 | M/s. Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector6A, IIE, SIDCUL, Haridwar249403 (U.K) | Dissolution | RDTL, Guwahati |
| 26. | Pantoprazole Gastro-resistant Tablets IP.. (PAN 40) | 22442076 | 07/2022 | 12/2024 | M/s. Alkem Health Science, A Unit Of Alkem Laboratories Limited, Unit-2, Samardung, Karek Block, P.O.: Namthang, South Sikkim – 737 137. | Assay and Dissolution in acid stage | RDTL, Guwahati |
| 27. | Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | BPH232520 | 08/2023 | 07/2025 | M/s. Aristo Pharmaceuticals Pvt. Ltd., Village: Makhnumajra. P.O.- Bhud, Baddi, Dist: Solan (H.P.)- 173205 | Identification and Assay/ Content of Cefpodoxime | RDTL, Guwahati |
| 28. | Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | BPD231045 | 04/2023 | 03/2025 | M/s. Aristo Pharmaceuticals Pvt. Ltd., Village: Makhnumajra. P.O.- Bhud, Baddi, Dist: Solan (H.P.)- 173205 | Identification and Assay/ Content of Cefpodoxime | RDTL, Guwahati |
| 29. | Amoxicillin And Potassium Clavulanate Tablets I.P. (CLAVAM 625) | 23443940 | 11/2023 | 04/2025 | M/s.Alkem Health Science, A Unit of Alkem Laboratories Limited, Unit-2, Samardung, Karek Block, P.O. Namthang, South Sikkim – 737 137. | Identification, Dissolution and Assay of Amoxicillin and Clavulanic Acid | RDTL, Guwahati |
| 30. | Fexofenadine Hydrochloride Tablets IP | T-2403971 | 03/2024 | 02/2026 | M/s. Oscar Remedies Pvt. Ltd., Oscar House, Badi Majra, Yamuna Nagar – 135 001 (HR) | Uniformity of Weight and Dissolution | RDTL, Guwahati |
| 31. | Ciprofloxacin Tablets IP 500 mg (CIPRODAC 500) | JKBD24009 | 01/2024 | 12/2026 | M/s.Cadila Pharmaceuticals Limited,, Industrial Growth Center, Samba -184 121, State of J & K | Dissolution of Ciprofloxacin | RDTL, Guwahati |
| 32. | Ramipril Tablets I.P. 2.5 mg | RT-231084 | 10/2023 | 09/2025 | M/s. Relief Biotech Pvt. Ltd., Khasra No. 72, Makhyali Dundi, Peerpura Road, Roorkee Bypass, Delhi Road, Manglour, Roorkee – 247656, Haridwar (U.K.). | Assay of Ramipril | RDTL, Guwahati |
| 33. | COMPOUND SODIUM LACTATE INJECTION I.P. (RL) | 03BF2475 | 04/2024 | 03/2027 | M/s. Paschim Banga Pharmaceuticals, NH- 31, TIN MILE HAT, SONAPUR HAT, P. S. CHOPRA, DISTRICT- UTTAR DINAJPORE, PIN-733214 (W.B.) | Bacterial Endotoxins Test | RDTL, Guwahati |
| 34. | Promethazine Hydrochloride Injection I.P. (PHENERGAN) | AHH0367 | 12/2022 | 11/2025 | M/s.Nitin Lifesciences Ltd., Rampur Road, Paonta Sahib, Dist. Sirmour – 173025 (H.P.), India | Assay of Promethazine Hydrochloride | RDTL, Guwahati |
| 35. | Paracetamol Paediatric Oral Suspension IP | V0244001 | 02/2024 | 01/2026 | M/s.Vivimed Labs Limited., Plot No. 25, Kundeshwari Village, Kashipur 244713, Uttarakhand. | Related Substances | CDTL-Mumbai |
| 36. | Aluminum Hydroxide, Simethicone & Magnesium Hydroxide Suspension (Spisam Gel) | L22455 | 12/2022 | 11/2024 | M/s.Aan Pharma Pvt. Ltd., 816/1, Rakanpur, Tal. Kalol, Dist. Gandhinagar, 380060, Gujarat, (India) | Assay / Content of Magnesium Hydroxide, Simethicone and Aluminium Hydroxide gel | CDTL-Mumbai |
| 37. | Gentamicin Sulphate Injection IP (P- Genta Injection) | PA022415 | 02/2024 | 01/2026 | M/s.Primus Pharmaceuticals, Sadhoura Road, Mouza ogli Khari Vill Asgarpur Majra, Kala Amb. Distt. Sirmour- (H. P.) 173030 | pH | CDTL-Mumbai |
| 38. | Fluconazole Tablets IP 150 mg (Flucse-150) | CHT23621 | 02/2024 | 01/2026 | M/s.Cureza Healthcare Pvt. Ltd., A.B. Road, Girwai- 474001 | Uniformity of weight | CDTL-Mumbai |
| 39. | BISACODYL TABLETS I.P. (Bisalax Tablets) | T-14996 | 12/2022 | 05/2025 | M/s. Karnani Pharmaceutical Pvt. Ltd., Fact. 38, Pharma City, Selaqui Dehradun- 248011 (Uttarakhand) | Dissolution (Buffer stage), Related substances and Assay of Bisacodyl | CDTL-Mumbai |
| 40. | Cetirizine Dihydrochloride Syrup (Citrize- P) | 275 | 06/2024 | 05/2026 | M/s. Arrow Pharma, Palia road, Hatod- 453111 | pH | CDTL, Hyderabad |
| 41. | Ifosfamide for Injection IP with Mesna Injection (Celofos 1000 Injection) | OL0492(for Ifosfamide), GN2064(for Mesna) | 08/2023 (for Ifosfamide) 08/2023 (for Mesna) | 07/2025 (for Ifosfamid e) 07/2026(f or Mesna) | M/s. Kwality Pharmaceuticals Limited,1-A, Industrial Area,Raja Ka Bagh, Tehsil Nurpur, Kangra- 176201(India) | Water and Assay of Ifosfamide | RDTL,Chandigarh |
| 42. | Aceclofenac 100 mg, Serratiopeptidas e 15 mg & Paracetamol 325 mg Tablets (ZEROD OL-SP TABLETS) | FND033076 AS | 08/2023 | 01/2026 | M/s. Ipca Laboratories Ltd.,393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim- 737 121 | Identification and Assay of Aceclofenac Serratiopeptidas e and Paracetamol | RDTL,Chandigarh |
| 43. | Ofloxacin and Ornidazole Intra Uterine Solution (Vet.) (UTROCLEAR- OZ SOLUTION) | V-2727 | 01/2024 | 12/2025 | M/s. Ramson Remedies,186-187, Industrial Focal Point, Amritsar. | Assay of Ofloxacin and Ornidazole | RDTL,Chandigarh |
| 44. | Bupropion Hydrochloride Extended Release Tablets USP (Nopion 150 Tablets) | GTD0768 | 11/2023 | 10/2025 | M/s. Digital Vision, 176, Mauza Ogli, Nahan road, Kala- Amb, Distt. Sirmour (H.P.)-17030 | Description and Assay of Bupropion Hydrochloride | RDTL,Chandigarh |
| 45. | Dextromethorph an Hydrobromide, Chlorpheniramin e Maleate and Phenylephrine Hydrochloride Syrup (COUGH- DM Cough Syrup) | SHL3037 | 11/2023 | 10/2025 | M/s.Sunfine Healthcare,Plot No. 63, Ind. Area Lodhimajra, Tehsil Baddi, Distt. Solan (H.P.) 173205 | Assay of Phenylphrine Hydrochloride | RDTL,Chandigarh |
| 46. | Cefoperazone and Sulbactam for Injection (KEFZONE-S INJECTION) | AB234007C | 06/2024 | 05/2026 | M/s.ANG Lifesciences India Ltd.,Village: Kishanpura, Nalagarh Road, Tehsil: Baddi, Distt.: Solan, HP- 174101 | Particulate Matter | RDTL,Chandigarh |
| 47. | Piperacillin and Tazobactam Injection IP (CASIDTAZ P Injection) | AB154006B | 06/2024 | 05/2026 | M/s.ANG Lifesciences India Ltd.,Village: Kishanpura, Nalagarh Road, Tehsil: Baddi, Distt.: Solan, HP- 174101 | Particulate Matter | RDTL,Chandigarh |
| 48. | Methylcobalami n Injection 2500 mcg (NUROFENS- 2500 Injection) | SRID24010 1 | 04/2024 | 09/2025 | M/s.Systole Remedies Pvt. Ltd.,Vill. Ogli, Kala Amb, Teh. Nahan, Distt. Sirmour (H.P.) – 173 030 | Particulate matter and Assay of Methylcobalamin | RDTL,Chandigarh |
| 49. | Torsemide Tablets IP 10 mg (Torverge- 10 Tablets) | GT7137A | 03/2023 | 02/2025 | M/s. J. M. LABORATORIES., Village- Bhanat, PO – Ghatti, Subathu Road, Solan (HP) 173211Himachal Pradesh – 173 205 | Assay of Torsemide | RDTL,Chandigarh |
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
List of Drugs declared as NSQ by STATES for the Month of September– 2024.
| B. State Laboratories | |||||||
| S.No | Product/Drug Name | Batch No. | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
| 1. | Neurotem-NT | CPT-2698 | Mar-24 | Feb-26 | Catasta Pharmaceuticals Plot No. 113, DIC, Industrial Area, Baddi Distt. Solan (H.P) Mrk. By : Cosway Biosciences Coprporate Office : Khasra No. 2054/1724, 1725 SCO No. 11 Baddi Barotiwala Road The. Baddi Distt. Solan H.P 173205 | The given Drug Sample does not comply to the contents of Assay with respect to Pregabalin ( 23.26% of claim) | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024- 25/1191 Dated: 05.09.2024. (Report attached as Annexure A) |
| 2. | Cefuroxime Axetil Tablets IP 500 mg (JKMSCL Supply) | JAK-23 | Jul-23 | Jun-25 | Agron Remedies Pvt Ltd Sarverkhera Moradabad Road Kashipur 244 713 (Uttarakhand) | The sample fails in the Description, Dissolution and Assay of Cefuroxime Axetil w.r.t the sample portion received as above | Combined Food & Drug Testing Laboratory Jammu (J&K) vide report on Form 13 bearing No. CFDL/J/2024-25/1120 Dated: 26.09.2024. (Report attached as Annexure B) |
| 3. | Loperamide Hydrochloride Tablets IP (JKMSCL Hospital Supply) | T-16201 | May-24 | Apr-26 | Karnani Pharmaceuticals Pvt. Ltd , 38 Pharma City , Selaqui Dehradun -248011 | The sample does not conform to IP with respect to the test for Dissolution & Assay | Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024-25/1311 Dated: 27.09.2024. (Report attached as Annexure C) |
| 4. | Floxages-OZ (Ofloxacin and Ornidazole Tablets IP) | SPY41223 | 12/23 | 11/26 | Suraksha Pharma pvt.Ltd, 410, Karondi, Roorkee-247 667, Uttarakhand | It fails the test ‘Dissolution’ as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 5. | Wintel 40 Tablets | HTN257D | 04/24 | 03/26 | Himalaya Meditek pvt.Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun – 248 197 | It fails the test ‘Dissolution’ as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 6. | Moxica -250 [Amoxicillin Dispersible Tablets IP 250 mg] | SD 243 | 08/23 | 07/25 | Indica Pharmaceuticals (P) Ltd, Bapunagar, Ahmedabad- 382 345 | It fails the test ‘Disintegration’ and ‘Uniformity of Dispersion’ specified in the Laboratory Protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 7. | Frusemide Injection IP 20 mg | FRIB-03 | 01/24 | 12/25 | Nestor Pharmaceuticals Ltd, 11, Western Extension Area, Faridabad -121001 | It fails the test ‘Sterility’ as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 8. | Cloxacillin Sodium Capsules IP 250 mg | CLCA-04 | 04/23 | 03/25 | Nestor Pharmaceuticals Ltd, 11, Western Extension Area, Faridabad -121001 | The sample does not conform to IP Standards with respect to ‘Descriptive part’ of hard gelatin capsules and further tests cannot be performed due to reasons secified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapuram |
| 9. | Fluorometholone Eye Drops IP | CHE-3044 | 05/23 | 04/25 | Cotec Healthcare pvt.Ltd, K.H.No.593/1, Roorkee, Dehradun Highway, Kishanpur, Roorkee- 247 667, UK | It fails the test ‘Uniformity of Volume’ and ‘Assay’ as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 10. | Panlib 40 Tablets | HTN 102A | 01/24 | 12/25 | Himalaya Meditek pvt.Ltd, Plot No. 35 & 36, Pharmacity, Selaqui, Industrial Area, Dehradun | It fails the test Dissolution’ and ‘Assay’ as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 11. | B – Cidal 625 | UT232859 | 03/24 | 08/25 | VADSP Pharmaceuticals, Plot No. 124, EPIP Indl.Area, Phase 1, Jharmajri, Baddi (HP)- 174103 | The content of Clavulanic acid is not with in the limit of ‘Schedule V’ of Drugs and Cosmetics Act & Rules thereunder | Drugs Testing Laboratory Thiruvananthapuram |
| 12. | Trypsin, Bromelain & Rutoside Trihydrate Tablets [Flavoshine] | TTF24065 | 06/24 | 11/25 | Tiruvision Medcare, Plot No. 177, HPSIDC, Indl.Area, Baddi, Dist Solan HP 173 205 | The sample fails the test ‘Disintegration’ specified in the Laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
| 13. | C Mont LC Kid 60 ml (Montelukast & Leveocetirizine Dihydrochloride syrup) | AL 23206 | 11/23 | 10/25 | Cian Healthcare Ltd, kh No.248, Village sisonia, Bhagwanpur, Roorkee, Haridwar, Uttarakhand- 247 661 | The content of montelukast is not within the limits of Schedule ‘V’ of Drugs & Cosmetics Act & Rules | Drugs Testing Laboratory Thiruvananthapuram |
| 14. | Yogaraja Guggulu Tablet | P 592324 | 10/23 | 09/26 | Oushadhi, The Pharmaceutical corporation (IM) , Kerala Ltd, Kuttanellur, Thrissur- 68 0014 | The sample does not conform to API Standards. It fails the tests ‘Total Ash’ as per API Standards. | Drugs Testing Laboratory Thiruvananthapuram |
| 15. | Telmisartan Tab IP 40 mg | D1153/24-25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14 | The sample does not conform to IP Standards with respective to ‘Descriptive part’ of tablets and further tests cannot be performed due to above reasons. | Drugs Testing Laboratory Thiruvananthapuram | ||
| 16. | Pantoprazole Inj.BP 40 mg | D 0923/24- 25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14 | It fails the test ‘Sterility’ specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram | ||
| 17. | Glimepiride Tab IP | D1272/24-25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14 | The sample fails the descriptive part for tablets as they are not sufficiently hard to withstand handling without crumbling or breaking and further tests cannot be performed due to above reason | Drugs Testing Laboratory Thiruvananthapuram | ||
| 18. | Cough Syrup | D 1278/24- 25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram- 14 | The sample fails the ‘Descriptive part’ for oral dosage forms of Schedule V of drugs and cosmetics Act and Rules, as the syrup contains red coloured suspended paticles | Drugs Testing Laboratory Thiruvananthapuram |
NOTE:
- NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Karnataka (PDF format), Thiruvanthapuram (Excel format), and Jammu Kashmir (Excel Format) for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
- State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Goa, Gujarat, Haryana, Himachal Pradesh, Manipur, Rajasthan, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry, Telangana, Delhi, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of August, 2024 as per DCG(I) Circular dated 09.02.2024.
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
